Unique microRNAs appear at different times during the course of a delayed-type hypersensitivity reaction in human skin

Experimental Dermatology

Volumn 24, Issue 12, 2015, Pages 953-957

  Gulati, Nicholas ^a   Løvendorf, Marianne B ^b,c   Zibert, John R ^b   Akat, Kemal M ^a   Renwick, Neil ^a   Tuschl, Thomas ^a   Krueger, James G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b LEO PHARMA A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Delayed type hypersensitivity; Diphencyprone; MicroRNA; Next generation sequencing

Indexed keywords

CYCLOPROPANE DERIVATIVE; DIPHENCYPRONE; HAPTEN; MICRORNA; MIRN21 MICRORNA, HUMAN; MIRN383 MICRORNA, HUMAN; MIRN503 MICRORNA, HUMAN; MIRN7 MICRORNA, HUMAN; TRANSCRIPTOME;

ADULT; DELAYED HYPERSENSITIVITY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; SKIN; TIME FACTOR; YOUNG ADULT;

ADULT; CYCLOPROPANES; FEMALE; HAPTENS; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; MICRORNAS; MIDDLE AGED; SKIN; TIME FACTORS; TRANSCRIPTOME; YOUNG ADULT;

EID: 85027916901     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12813     Document Type: Article

References (30)

1. Upitis J A, Krol A. J Cutan Med Surg 2002: 6: 214–217.
2. Damian D L, Saw R P M, Thompson J F. J Surg Oncol 2014: 109: 308–313.
3. Freyschmidt-Paul P, Happle R, McElwee K J et al. J Investig Dermatol Symp Proc 2003: 8: 12–17.
4. Gulati N, Suarez-Fari~nas M, Fuentes-Duculan J et al. J Invest Dermatol 2014: 134: 2531–2540.
5. Baltimore D, Boldin M P, O’Connell R M et al. Nat Immunol 2008: 9: 839–845.
6. Friedman R C, Farh K K-H, Burge C B et al. Genome Res 2009: 19: 92–105.
7. Sayed D, Abdellatif M. Physiol Rev 2011: 91: 827–887.
8. Guinea-Viniegra J, Jimenez M, Schonthaler H B et al. Sci Transl Med 2014: 6: 225re1.
9. Vennegaard M T, Bonefeld C M, Hagedorn P H et al. Contact Dermatitis 2012: 67: 298–305.
10. Hafner M, Landgraf P, Ludwig J et al. Methods 2008: 44: 3–12.
11. Farazi T A, Brown M, Morozov P et al. Methods 2012: 58: 171–187.
12. Hafner M, Renwick N, Farazi T A et al. Methods 2012: 58: 164–170.
13. Robinson M D, McCarthy D J, Smyth G K. Bioinformatics 2010: 26: 139–140.
14. Schmittgen T D, Livak K J. Nat Protoc 2008: 3: 1101–1108.
15. Sonkoly E, Janson P, Majuri M-L et al. J Allergy Clin Immunol 2010: 126: 581–589.e1–20.
16. Zibert J R, Løvendorf M B, Litman T et al. J Dermatol Sci 2010: 58: 177–185.
17. Bryniarski K, Ptak W, Jayakumar A et al. J Allergy Clin Immunol 2013: 132: 170–181.
18. Jiang H, Jin C, Liu J et al. OMICS 2014: 18: 196–206.
19. Uppal A, Wightman S C, Mallon S et al. Oncotarget 2015: 6: 3540–3552.
20. Liu X, Shi H, Liu B et al. Acta Biochim Biophys Sin 2015: 47: 431–440.
21. Chen X-P, Chen Y-G, Lan J-Y et al. Cancer Lett 2014: 353: 201–210.
22. Li S, Meng H, Zhou F et al. Pathol Res Pract 2013: 209: 179–183.
23. Li C, Nie H, Wang M et al. Cancer Lett 2012: 320: 189–197.
24. Jiang N, Chen W-J, Zhang J-W et al. Oncotarget 2015: 6: 7866–7879.
25. Gu Y, Cheng Y, Song Y et al. PLoS ONE 2014: 9: e102602.
26. Fabian M R, Sonenberg N, Filipowicz W. Annu Rev Biochem 2010: 79: 351–379.
27. Zhu W, Streicher K, Shen N et al. BMC Med Genomics 2012: 5: 53.
28. Løvendorf M B, Mitsui H, Zibert J R et al. Exp Dermatol 2014: 24: 187–193.
29. Lu T X, Munitz A, Rothenberg M E. J Immunol 2009: 182: 4994–5002.
30. Lu T X, Hartner J, Lim E-J et al. J Immunol 2011: 187: 3362–3373.